Factors Causing Falsely Low IGF-1 Levels
Falsely low IGF-1 levels can result from heterophilic antibody interference in immunoassays, malnutrition, uncontrolled diabetes, hypothyroidism, liver disease, and certain medications—all of which must be excluded before diagnosing growth hormone deficiency based on low IGF-1 values 1.
Assay-Related Interference
Heterophilic Antibodies
The most important technical cause of falsely low IGF-1 is heterophilic antibody interference in modern immunometric assays (IRMA and chemiluminescent assays). When IGF-1 levels appear low but don't fit the clinical picture, this interference should be strongly suspected 2. The diagnosis can be confirmed by:
- Retesting with heterophilic blocking tubes containing specific blocking reagents
- Measuring IGF-1 bioactivity using kinase receptor activation assays, which will be normal despite low immunoassay results 2
This represents a critical pitfall because it can lead to unnecessary diagnostic workups and inappropriate therapeutic interventions 2.
IGF Binding Protein Interference
IGFBPs bind approximately 98% of circulating IGF-1, which significantly reduces detectable immunoreactive IGF-1 in samples 3. This necessitates multiple pre-treatment steps in assays that can reduce reproducibility and complicate result interpretation 3. Different assay methodologies handle IGFBP interference variably, contributing to discordant results between laboratories 4.
Physiological and Clinical Factors
Nutritional Status
Malnutrition is a major cause of low IGF-1 independent of GH status 1. Nutrient intake directly regulates IGF-1 synthesis, and inadequate caloric or protein intake will suppress IGF-1 levels even with normal GH secretion 5.
Endocrine Disorders
Several hormonal conditions cause genuinely low IGF-1 that may be mistaken for GH deficiency:
- Hypothyroidism: T4 is required for normal IGF-1 synthesis 5
- Uncontrolled diabetes: Impairs IGF-1 production 1
- Hypercortisolism: Cortisol affects IGF-1 regulation 5
- Hypogonadism: Sex steroids influence IGF-1 levels 5
Liver Disease
Since IGF-1 is primarily synthesized in the liver, hepatic dysfunction of any cause will reduce IGF-1 production regardless of GH status 1.
Demographic Factors
Age
IGF-1 levels decline significantly with age 6. In adults over 40 years, IGF-1 has reduced accuracy as a screening test for GH deficiency because age-related decline overlaps with pathological reductions 1. Only 39% of GH-deficient patients aged 57 years or above had IGF-1 below -2 SD, compared to 57% of those aged 41 years or below 6.
Gender
Women have lower mean IGF-1 levels than men, which can affect interpretation 6. This gender difference must be accounted for when using reference ranges.
Clinical Context for Interpretation
Before attributing low IGF-1 to GH deficiency, the Endocrine Society guidelines emphasize that very low IGF-1 alone is insufficient for diagnosis 7. The guidelines state that:
- IGF-1 increases the likelihood of true GH deficiency when combined with abnormal stimulation testing 7
- In adults with hypothalamic-pituitary disease and multiple pituitary hormone deficiencies, an IGF-1 level <84 μg/L (or SDS <-3 for adults over age 28) indicates 99% probability of GH deficiency 1
- However, this only applies after excluding the reversible causes listed above 1
Practical Algorithm
When encountering low IGF-1:
First, verify the result doesn't fit clinically - if suspicion is high for assay interference, retest with heterophilic blocking tubes 2
Exclude reversible causes systematically:
- Check thyroid function (TSH, free T4)
- Assess nutritional status and recent weight loss
- Evaluate glycemic control (HbA1c, fasting glucose)
- Review liver function tests
- Consider gonadal status
- Review medication list (particularly relevant for falsely elevated, but worth noting) 8
Only after exclusions, consider true GH deficiency in the appropriate clinical context (known pituitary disease, multiple hormone deficiencies) 7, 1
The key pitfall is assuming low IGF-1 equals GH deficiency without systematic exclusion of these confounding factors, which can lead to misdiagnosis and inappropriate GH replacement therapy.